11 Combination Immunotherapy Approaches Elevating Cancer Vaccine Response Rates in 2026
ASCO's 2026 Annual Meeting highlighted combination immunotherapy as the dominant theme in cancer vaccine clinical development, with 47 combination trial abstracts presented — more than double the number in 2023 — reflecting a field-wide consensus that cancer vaccines deliver their maximum clinical benefit when integrated with complementary immunological mechanisms rather than...
0 Comments 0 Shares 288 Views 0 Reviews